JP2024510564A5 - - Google Patents
Info
- Publication number
- JP2024510564A5 JP2024510564A5 JP2023553124A JP2023553124A JP2024510564A5 JP 2024510564 A5 JP2024510564 A5 JP 2024510564A5 JP 2023553124 A JP2023553124 A JP 2023553124A JP 2023553124 A JP2023553124 A JP 2023553124A JP 2024510564 A5 JP2024510564 A5 JP 2024510564A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- dhe
- dried powder
- minutes
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163156111P | 2021-03-03 | 2021-03-03 | |
| US63/156,111 | 2021-03-03 | ||
| PCT/US2022/018306 WO2022187222A1 (en) | 2021-03-03 | 2022-03-01 | Dihydroergotamine dry power formulations and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024510564A JP2024510564A (ja) | 2024-03-08 |
| JP2024510564A5 true JP2024510564A5 (https=) | 2025-03-10 |
Family
ID=80781023
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023553124A Pending JP2024510564A (ja) | 2021-03-03 | 2022-03-01 | ジヒドロエルゴタミン乾燥粉末製剤及びその使用方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240033218A1 (https=) |
| EP (1) | EP4301334A1 (https=) |
| JP (1) | JP2024510564A (https=) |
| KR (1) | KR20230152083A (https=) |
| CN (1) | CN117222401A (https=) |
| AU (2) | AU2022228443B2 (https=) |
| BR (1) | BR112023017538A2 (https=) |
| CA (1) | CA3210442A1 (https=) |
| IL (1) | IL305506A (https=) |
| MX (1) | MX2023010120A (https=) |
| WO (1) | WO2022187222A1 (https=) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4069819A (en) | 1973-04-13 | 1978-01-24 | Societa Farmaceutici S.P.A. | Inhalation device |
| IT1228459B (it) | 1989-02-23 | 1991-06-19 | Phidea S R L | Inalatore con svuotamento regolare e completo della capsula. |
| WO2008097664A1 (en) * | 2007-02-11 | 2008-08-14 | Map Pharmaceuticals, Inc. | Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile |
| AP3138A (en) * | 2009-04-24 | 2015-02-28 | Iceutica Pty Ltd | Production of encapsulated nanoparticles at high volume fractions |
| CN103200938B (zh) * | 2010-08-30 | 2018-07-31 | 普马特里克斯营业公司 | 干燥粉末配方及用于治疗肺部疾病的方法 |
| PT3470057T (pt) * | 2010-09-29 | 2021-12-03 | Pulmatrix Operating Co Inc | Pós secos catiónicos compreendendo sais de magnésio |
| AU2013361337A1 (en) * | 2012-12-21 | 2015-07-09 | Map Pharmaceuticals, Inc. | 8'-Hydroxy-Dihydroergotamine compounds and compositions |
| US20140179705A1 (en) * | 2012-12-21 | 2014-06-26 | Map Pharmaceuticals, Inc. | 8'-hydroxy-dihydroergotamine compounds and compositions |
| AU2014248455B2 (en) * | 2013-04-01 | 2018-12-06 | Pulmatrix Operating Company, Inc. | Tiotropium dry powders |
| IL265913B2 (en) * | 2016-10-14 | 2024-07-01 | Pulmatrix Operating Co Inc | Respirable Dry Powder Comprising Itraconazole In Crystalline Form And Its Use For Manufacturing A Medicament For Treating Fungal Infection |
-
2022
- 2022-03-01 BR BR112023017538A patent/BR112023017538A2/pt unknown
- 2022-03-01 CN CN202280031563.XA patent/CN117222401A/zh active Pending
- 2022-03-01 IL IL305506A patent/IL305506A/en unknown
- 2022-03-01 MX MX2023010120A patent/MX2023010120A/es unknown
- 2022-03-01 JP JP2023553124A patent/JP2024510564A/ja active Pending
- 2022-03-01 AU AU2022228443A patent/AU2022228443B2/en active Active
- 2022-03-01 KR KR1020237032645A patent/KR20230152083A/ko active Pending
- 2022-03-01 EP EP22710901.4A patent/EP4301334A1/en active Pending
- 2022-03-01 US US18/548,896 patent/US20240033218A1/en active Pending
- 2022-03-01 WO PCT/US2022/018306 patent/WO2022187222A1/en not_active Ceased
- 2022-03-01 CA CA3210442A patent/CA3210442A1/en active Pending
-
2025
- 2025-10-21 AU AU2025256073A patent/AU2025256073A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102946868B (zh) | 包含抗毒蕈碱药的干粉制剂 | |
| JP5877201B2 (ja) | 肺疾患を治療するための乾燥粉末製剤および方法 | |
| US20220296559A1 (en) | Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI) | |
| JP2023549226A5 (https=) | ||
| AU2003218307B8 (en) | Pulmonary delivery for levodopa | |
| AU2020328223B2 (en) | Pharmaeutical composition comprising ensifentrine | |
| JP2004517127A (ja) | ポリエン抗真菌剤の肺送達 | |
| RS57061B1 (sr) | Formulacija suvog praha koja uključuje inhibitor fosfodiesteraze | |
| JP2012522009A (ja) | 肺炎および人工呼吸器関連気管気管支炎を治療および予防するための方法 | |
| JP2013540123A5 (https=) | ||
| JP2006514679A (ja) | トロスピウム含有組成物 | |
| JP2021522161A5 (https=) | ||
| CN1972730A (zh) | 格隆溴铵用于治疗儿童哮喘 | |
| AU2020250325A1 (en) | Levodopa formulations for rapid relief of parkinson's disease | |
| JP2025122121A (ja) | 肺線維症を処置するための方法及び組成物 | |
| JP2024510564A5 (https=) | ||
| JP2018058881A (ja) | 医薬組成物 | |
| WO2018206618A1 (en) | A process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic | |
| IL305506A (en) | Dry powder formulations of dihydroergotamine and their use | |
| JP2025526811A (ja) | 吸入可能なエピネフリン製剤 | |
| JP7239604B2 (ja) | 甲状腺ホルモンを含む吸入用の薬学的乾燥粉末組成物 | |
| KR102259824B1 (ko) | 보센탄을 함유한 약학 제제 | |
| JP2000080034A (ja) | 風邪用組成物 | |
| JP2025511232A5 (https=) | ||
| JP2025506019A (ja) | トレプロスチニルイロプロスト併用療法 |